Interactive Investor
>>

Cassiopea SpA (SIX:SKIN) Share Price

SKIN

Cassiopea SpA

European company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XSWX

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It is focused on developing and commercializing differentiated medical dermatology products. The company's focus is on the topical treatment of acne; Androgenic Alopecia, (or AGA); and genital warts. Its portfolio comprises four unencumbered clinical candidates namely: Winlevi, for the treatment of acne; Breezula, for the topical treatment of AGA; CB-06-02, for the treatment of genital warts; and CB-06-01, for the treatment of acne.Cassiopea SpA is a clinical-stage specialty pharmaceutical company focused on developing and commercializing differentiated medical dermatology products. Its focus is on the topical treatment of acne; Androgenic Alopecia, (or AGA); and genital warts.

SIX:SKIN

IT0005108359

CHF

Loading...

Loading Comparison

Latest SKIN News